Core Viewpoint - Guangzhou Pharmaceutical Group is transitioning from a traditional Chinese medicine-focused pharmaceutical enterprise to a modern, digital, technological, and international pharmaceutical group [1] Group 1: Strategic Focus Areas - The company is closely monitoring national policies that support the high-quality development of traditional Chinese medicine and the expedited approval process for innovative drugs [1] - There is an emphasis on investing in platform construction to keep pace with the innovative drug sector [1] - The company plans to expand its product influence and market presence internationally, particularly through collaborations with European firms in the innovative drug field [1]